Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?
Kekre N, Tokessy M, Mallick R, McDiarmid S, Huebsch L, Bredeson C, Allan D, Tay J, Tinmouth A, Sheppard D. Kekre N, et al. Among authors: huebsch l. Biol Blood Marrow Transplant. 2013 Dec;19(12):1719-24. doi: 10.1016/j.bbmt.2013.09.013. Epub 2013 Oct 5. Biol Blood Marrow Transplant. 2013. PMID: 24099958 Free article.
Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
Bryant A, Mallick R, Huebsch L, Allan D, Atkins H, Anstee G, Sabloff M, Scrivens N, Maze D, Bredeson C, Kekre N. Bryant A, et al. Among authors: huebsch l. Biol Blood Marrow Transplant. 2017 Dec;23(12):2096-2101. doi: 10.1016/j.bbmt.2017.08.007. Epub 2017 Aug 15. Biol Blood Marrow Transplant. 2017. PMID: 28821454 Free article.
Reduced hemoglobin on day of peripheral blood progenitor cell collection is associated with low graft content of vascular progenitors and increased toxicity after autologous hematopoietic stem cell transplantation.
Kasbia G, Al-Gahtani F, Tay J, Labonté L, Tinmouth A, Ramsay T, Gillingham A, Yang L, Halpenny M, Giulivi A, McDiarmid S, Huebsch L, Allan DS. Kasbia G, et al. Among authors: huebsch l. Transfusion. 2008 Nov;48(11):2421-8. doi: 10.1111/j.1537-2995.2008.01876.x. Epub 2008 Jul 30. Transfusion. 2008. PMID: 18673346
A single-institution analysis of the utility of pre-induction ejection fraction measurement in patients newly diagnosed with acute myeloid leukemia.
Bryant A, Sheppard D, Sabloff M, Delbaere M, Maze R, Allan D, Atkins H, Bence-Bruckler I, Faught C, Huebsch L, Tay J, Zanke B, Bredeson C. Bryant A, et al. Among authors: huebsch l. Leuk Lymphoma. 2015 Jan;56(1):135-40. doi: 10.3109/10428194.2014.883072. Epub 2014 Jul 17. Leuk Lymphoma. 2015. PMID: 24913512
Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation.
Christou G, Kekre N, Petrcich W, Tokessy M, Neurath D, Giulivi A, Saidenberg E, McDiarmid S, Atkins H, Bence-Bruckler I, Bredeson C, Huebsch L, Sabloff M, Sheppard D, Tay J, Tinmouth A, Allan DS. Christou G, et al. Among authors: huebsch l. Transfusion. 2015 Feb;55(2):253-8. doi: 10.1111/trf.12817. Epub 2014 Aug 15. Transfusion. 2015. PMID: 25125085 Clinical Trial.
Outcomes of both abbreviated hyper-CVAD induction followed by autologous hematopoietic cell transplantation and conventional chemotherapy for mantle cell lymphoma: a 10-year single-centre experience with literature review.
Alwasaidi TA, Hamadah A, Altouri S, Tay J, McDiarmid S, Faught C, Allan D, Huebsch L, Bredeson C, Bence-Bruckler I. Alwasaidi TA, et al. Among authors: huebsch l. Cancer Med. 2015 Dec;4(12):1817-27. doi: 10.1002/cam4.543. Epub 2015 Oct 3. Cancer Med. 2015. PMID: 26432256 Free PMC article. Review.
77 results